Per Bo Pedersen Fischer
Algemeen Directeur bij Helion Biotech ApS
Actieve functies van Per Bo Pedersen Fischer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Helion Biotech ApS
 Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | Algemeen Directeur | 01-01-2008 | - |
| Oprichter | 01-01-2008 | - | |
Minervax ApS
 Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Algemeen Directeur | 05-04-2011 | - |
Loopbaan van Per Bo Pedersen Fischer
Eerdere bekende functies van Per Bo Pedersen Fischer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Azanta Danmark A/S
 Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark. | President | 01-01-2000 | 01-01-2003 |
| BAVARIAN NORDIC A/S | Corporate Officer/Principal | - | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - | - |
Opleiding van Per Bo Pedersen Fischer
| University of Southern Denmark | Graduate Degree |
| University of Oxford | Doctorate Degree |
Statistieken
Internationaal
| Denemarken | 7 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
| President | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| BAVARIAN NORDIC A/S | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Azanta Danmark A/S
Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark. | Health Technology |
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | Health Technology |
Minervax ApS
Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Health Technology |
